Research on obtaining of a pharmaceutical substance for the complex therapy of inflammatory bowel diseases

According to medical data, inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD), are global diseases of the 21st century, characteristic of developed countries, the treatment of which requires a systematic approach with an emphasis on safety, which may be implemented through the use of anti-inflammatory phytosubstances. Prospects for the medical use of raw materials Matricaria aurea (L.) Schultz-Bip. (M.aurea), which grows in Syria, are due to the wide use in ethnomedicine for the treatment of various inflammatory diseases, including in the complex therapy of IBD. For the development of phytopreparations, some numerical indicators of M.aurea raw materials were determined: fractional composition, moisture content, bulk density of crushed dried material, 70 % alcohol was chosen as an extractant, the content of extractives, the absorption coefficient of the extractant and the ash content were determined.